Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies [PDF]
Indoxyl sulfate is an extensively studied uremic solute. It is a small molecule that is more than 90% bound to plasma proteins. Indoxyl sulfate is derived from the breakdown of tryptophan by colon microbes.
Sheldon C. Leong, Tammy L. Sirich
doaj +5 more sources
Indoxyl Sulfate, a Uremic Endotheliotoxin [PDF]
Chronic kidney disease (CKD) is associated with a high prevalence of cardiovascular diseases. During CKD, the uremic toxin indoxyl sulfate (IS)—derived from tryptophan metabolism—accumulates.
Guillaume Lano +2 more
doaj +5 more sources
-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis [PDF]
PurposeIndoxyl sulfate and p-cresyl sulfate are important protein-bound uremic retention solutes whose levels can be partially reduced by renal replacement therapy. These solutes originate from intestinal bacterial protein fermentation and are associated
Hye Sun Hyun +2 more
doaj +3 more sources
Indoxyl Sulfate and Incident Peripheral Artery Disease in Hemodialysis Patients [PDF]
Peripheral artery disease (PAD) is highly prevalent among patients with chronic kidney disease (CKD) and portends a very poor prognosis. Indoxyl sulfate has been shown to induce atherothrombosis and impaired neovascularization in uremic mice.
Ting-Yun Lin +3 more
doaj +3 more sources
Correlation Between Indoxyl Sulfate in Chronic Kidney Disease and Olfactory Dysfunction [PDF]
Introduction: Olfactory dysfunction is prevalent among individuals with chronic kidney disease (CKD), with prevalence escalating alongside disease severity.
Irnanda Nasution +6 more
doaj +2 more sources
Indoxyl Sulfate in the Gut–Kidney Axis: Pathophysiology and Clinical Significance in CKD-Associated Colorectal Cancer [PDF]
Chronic Kidney Disease (CKD) and Colorectal Cancer (CRC) share a profound epidemiological link, supported by Mendelian randomization studies suggesting causality.
Hidehisa Shimizu, Toshimitsu Niwa
doaj +2 more sources
Correlation of Indoxyl Sulfate to Hearing Impairment in Chronic Kidney Disease Patients [PDF]
Introduction: Chronic Kidney Disease (CKD) is considered a public health issue because its frequency is increasing in adults. When a person experiences renal failure, one of the most researched solutes that builds up in plasma is indoxyl sulfate.
Fadillah Sanjani +7 more
doaj +2 more sources
Indoxyl sulfate impairs valsartan-induced neovascularization
Studies revealed that the use of renin-angiotensin-aldosterone system antagonism is not associated with a statistically significant reduction in the risk of cardiovascular events in patients with chronic kidney disease (CKD) compared with that in the ...
Ko-Lin Kuo +5 more
doaj +4 more sources
Retention of indoxyl sulfate in different genotypes of ABCC2 may explain variation in tacrolimus pharmacokinetics [PDF]
Background Microbiota-derived toxins indoxyl sulfate and hippuric acid were previously reported to be associated with altered pharmacokinetics of the immunosuppressant tacrolimus in liver transplant recipients, and ABC transporter proteins are likely to ...
Jing Wang +5 more
doaj +3 more sources
Myostatin Exacerbates Endothelial Dysfunction Induced by Uremic Toxin Indoxyl Sulfate and Is Associated with Hemodialysis Arteriovenous Access Complications [PDF]
Hemodialysis patients exhibit endothelial dysfunction, contributing to elevated cardiovascular risk and complications of the arteriovenous access. These patients have elevated serum levels of myostatin, a member of the transforming growth factor-β (TGFβ)
Justine Solignac +10 more
doaj +2 more sources

